VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 176 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $678,901 | +901.3% | 157,153 | +1427.4% | 0.00% | – |
| Q2 2023 | $67,804 | -77.1% | 10,289 | -74.3% | 0.00% | -100.0% |
| Q4 2022 | $296,250 | +196.2% | 40,088 | +296.2% | 0.00% | – |
| Q3 2022 | $100,000 | -64.9% | 10,118 | -49.9% | 0.00% | -100.0% |
| Q2 2019 | $285,000 | -31.3% | 20,197 | -18.0% | 0.00% | 0.0% |
| Q1 2018 | $415,000 | +159.4% | 24,617 | +134.4% | 0.00% | – |
| Q4 2017 | $160,000 | -59.2% | 10,500 | -52.1% | 0.00% | -100.0% |
| Q3 2017 | $392,000 | +83.2% | 21,900 | -14.5% | 0.00% | +100.0% |
| Q1 2016 | $214,000 | -40.2% | 25,600 | -33.4% | 0.00% | -50.0% |
| Q4 2015 | $358,000 | -4.3% | 38,460 | +15.8% | 0.00% | -33.3% |
| Q3 2015 | $374,000 | +165.2% | 33,200 | +199.1% | 0.00% | +200.0% |
| Q2 2015 | $141,000 | -96.2% | 11,100 | -95.1% | 0.00% | -97.6% |
| Q1 2014 | $3,664,000 | +332.1% | 225,480 | +114.7% | 0.04% | +200.0% |
| Q2 2013 | $848,000 | – | 105,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |